Skip to main content
S. 331 119th Congress Senate

HALT Fentanyl Act

Official title: A bill to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.

Introduced: January 30, 2025 Introduced by: Bill Cassidy Republican · Louisiana See on congress.gov
Crime and Law Enforcement Administrative law and regulatory proceduresDepartment of JusticeDrug trafficking and controlled substancesLicensing and registrationsResearch administration and funding
 Everywhere this bill has been 37 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 16, 2025
Became Public Law No: 119-26.
Jul 16, 2025
Signed by President.
Jul 8, 2025
Presented to President.
Jun 12, 2025
On passage Passed by the Yeas and Nays: 321 - 104 (Roll no. 166). (text: 6/11/2025 CR H2625-2627)
Jun 12, 2025
Motion to reconsider laid on the table Agreed to without objection.
Jun 12, 2025
Considered as unfinished business. (consideration: CR H2806)
Jun 11, 2025
POSTPONED PROCEEDINGS - At the conclusion of debate on S. 331, the Chair put the question on passage of the bill and by voice vote, announced that the ayes had prevailed. Mr. Pallone demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.
Jun 11, 2025
The previous question was ordered pursuant to the rule.
Jun 11, 2025
DEBATE - The House proceeded with one hour of debate on S. 331.
Jun 11, 2025
Rule provides for consideration of H.R. 884, H.R. 2056, H.R. 2096 and S. 331. The resolution provides for consideration of H.R. 884, H.R. 2056, H.R. 2096, and S. 331 under a closed rule with one hour of general debate for each bill. The resolution provides for one motion to recommit on H.R. 884, H.R. 2056, and H.R. 2096, and one motion to commit on S. 331.
Jun 11, 2025
Considered under the provisions of rule H. Res. 489. (consideration: CR H2625-2633)
Jun 10, 2025
Rule H. Res. 489 passed House.
Jun 9, 2025
Rules Committee Resolution H. Res. 489 Reported to House. Rule provides for consideration of H.R. 884, H.R. 2056, H.R. 2096 and S. 331. The resolution provides for consideration of H.R. 884, H.R. 2056, H.R. 2096, and S. 331 under a closed rule with one hour of general debate for each bill. The resolution provides for one motion to recommit on H.R. 884, H.R. 2056, and H.R. 2096, and one motion to commit on S. 331.
Mar 18, 2025
Received in the House.
Mar 18, 2025
Held at the desk.
Mar 14, 2025
Message on Senate action sent to the House.
Mar 14, 2025
Passed Senate with an amendment by Yea-Nay Vote. 84 - 16. Record Vote Number: 127.
Mar 14, 2025
Passed/agreed to in Senate: Passed Senate with an amendment by Yea-Nay Vote. 84 - 16. Record Vote Number: 127.
Mar 14, 2025
The committee substitute agreed to by Unanimous Consent.
Mar 14, 2025
Considered by Senate. (consideration: CR S1762-1765)
Mar 13, 2025
Considered by Senate. (consideration: CR S1735)
Mar 13, 2025
Cloture on the measure invoked in Senate by Yea-Nay Vote. 84 - 15. Record Vote Number: 124. (CR S1735)
Mar 11, 2025
Cloture motion on the measure presented in Senate. (CR S1659)
Mar 11, 2025
Considered by Senate. (consideration: CR S1659)
Mar 10, 2025
Measure laid before Senate by motion.
Mar 10, 2025
Motion to proceed to consideration of measure agreed to in Senate by Voice Vote. (consideration: CR S1623)
Mar 10, 2025
Motion to proceed to measure considered in Senate. (CR S1623)
Mar 6, 2025
Cloture on the motion to proceed to the measure invoked in Senate by Yea-Nay Vote. 82 - 12. Record Vote Number: 110. (CR S1596)
Mar 6, 2025
Motion to proceed to measure considered in Senate. (CR S1596)
Mar 5, 2025
Motion to proceed to measure considered in Senate. (CR S1521)
Mar 4, 2025
Cloture motion on the motion to proceed to the measure presented in Senate. (CR S1488)
Mar 4, 2025
Motion to proceed to consideration of measure made in Senate. (CR S1488)
Mar 3, 2025
Placed on Senate Legislative Calendar under General Orders. Calendar No. 18.
Mar 3, 2025
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Feb 27, 2025
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Jan 30, 2025
Read twice and referred to the Committee on the Judiciary.
Jan 30, 2025
Introduced in Senate
 Votes taken on this bill 5
DateChamberWhat was voted onResultYes–No
Jun 12, 2025 House · vote #166 On Passage Passed 321–104 See who voted →
Mar 14, 2025 Senate · vote #127 On Passage of the Bill S. 331 Passed 84–16 See who voted →
Mar 13, 2025 Senate · vote #124 On the Cloture Motion S. 331 Agreed To 84–15 See who voted →
Mar 6, 2025 Senate · vote #110 On Cloture on the Motion to Proceed S. 331 Agreed To 82–12 See who voted →
Jun 16, 1999 Senate · vote #169 On Passage of the Bill S. 331 Passed 99–0 See who voted →
 Amendments to this bill 35

Amendments propose changes to this bill. Members vote on amendments separately before the final bill vote. An agreed amendment becomes part of the bill; a failed amendment does not.

AmendmentSponsorPurposeStatusLatest action
SAMDT 1,237 Grassley, Chuck To improve the bill. No recorded outcome Mar 14, 2025
SAMDT 1,265 Thune, John – No recorded outcome –
SAMDT 1,264 Thune, John – No recorded outcome –
SAMDT 1,263 Thune, John – No recorded outcome –
SAMDT 1,262 Thune, John – No recorded outcome –
SAMDT 1,261 Thune, John – No recorded outcome –
SAMDT 1,260 Cornyn, John – No recorded outcome –
SAMDT 1,259 Sullivan, Dan – No recorded outcome –
SAMDT 1,258 Warnock, Raphael G. – No recorded outcome –
SAMDT 1,257 Hirono, Mazie K. – No recorded outcome –
SAMDT 1,256 Hawley, Josh – No recorded outcome –
SAMDT 1,255 Hawley, Josh – No recorded outcome –
SAMDT 1,254 Durbin, Richard J. – No recorded outcome –
SAMDT 1,253 Durbin, Richard J. – No recorded outcome –
SAMDT 1,252 Durbin, Richard J. – No recorded outcome –
SAMDT 1,251 Durbin, Richard J. – No recorded outcome –
SAMDT 1,250 Durbin, Richard J. – No recorded outcome –
SAMDT 1,249 Warnock, Raphael G. – No recorded outcome –
SAMDT 1,248 Hickenlooper, John W. – No recorded outcome –
SAMDT 1,247 Risch, James E. – No recorded outcome –
SAMDT 1,246 Merkley, Jeff – No recorded outcome –
SAMDT 1,245 Merkley, Jeff – No recorded outcome –
SAMDT 1,244 Scott, Rick – No recorded outcome –
SAMDT 1,243 Coons, Christopher A. – No recorded outcome –
SAMDT 1,242 Coons, Christopher A. – No recorded outcome –
SAMDT 1,241 Cortez Masto, Catherine – No recorded outcome –
SAMDT 1,240 Cortez Masto, Catherine – No recorded outcome –
SAMDT 1,239 Blunt Rochester, Lisa – No recorded outcome –
SAMDT 1,238 Luján, Ben Ray – No recorded outcome –
SAMDT 1,236 Booker, Cory A. – No recorded outcome –
SAMDT 1,235 Booker, Cory A. – No recorded outcome –
SAMDT 1,234 Booker, Cory A. – No recorded outcome –
SAMDT 1,233 Booker, Cory A. – No recorded outcome –
SAMDT 1,232 Hassan, Margaret Wood – No recorded outcome –
SAMDT 1,231 Welch, Peter – No recorded outcome –
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action July 16, 2025

Became Public Law No: 119-26.

 Plain-English summary Congressional Research Service

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act

This act permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Under the act, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).

Additionally, the act establishes a new, alternative registration process for certain schedule I research.

The act also makes several other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

Finally, the act expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

 Related & companion bills 2
 Committees of jurisdiction 1
 Lobbying activity 59

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 59 filings →
Cite this page click to expand
APA
U.S. Congress. (2026). S. 331: HALT Fentanyl Act. 119th Congress. Open America. https://openamerica.io/bill/119-S-331/
MLA
"S. 331: HALT Fentanyl Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-331/.
Bluebook (legal)
S. 331, 119th Cong. (2026), https://openamerica.io/bill/119-S-331/.
Markdown link
[S. 331: HALT Fentanyl Act](https://openamerica.io/bill/119-S-331/)
Report a problem